Investor Relations · Company Profile · Stock Quote · Contact Us · Pierre Van Damme, M.D., Ph.D. · John D. Grabenstein, Ph.D., R.Ph. · Damian Braga · Adam Finn, M.D., ...
People also ask
Is VBI a good stock to buy?
Who owns VBIV?
What is the stock price prediction for Vbiv?
Why did VBIV stock drop?
Director of Corporate Communications & Investor Relations, N/A, N/A, N/A. Ms. Athena Kartsaklis, Senior VP of Finance, Chief Compliance Officer & Principal ...
... Annual Report on Form 10-K filed with the Securities ... NASDAQ: VBIV. eVLPs are a 3rd ... NASDAQ: VBIV. Summary. Page 52. 52. NASDAQ: VBIV. Jeff Baxter. President ...
Missing: relations | Show results with:relations
(Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno- ...
Get the latest insights on VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) with press releases and corporate news to help you in your trading and ...
Check out our VBIV stock analysis, current VBIV quote, charts, and historical prices for Vbi Vaccines Inc CS stock.
See the latest VBI Vaccines Inc stock price (VBIV:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Email: ir@vbivaccines.com. VBI Investor Contact. Nell Beattie. Director, Corporate Development and Investor Relations. Phone: (617) 830-3031 x128. Email ...
VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) Earnings ...
www.nasdaq.com › ... › Stocks › VBIV
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...